LEADER 01596nam  2200421Ia 450 
001 9910696948203321
005 20230902161549.0
035   $a(CKB)5470000002383410
035   $a(OCoLC)551138168
035   $a(EXLCZ)995470000002383410
100   $a20100311d2004      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $e"help-seeking" and other disease awareness communications by or on behalf of drug and device firms
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,$d[2004]
215   $a1 electronic resource (7 pages)
300   $a"Center for Biologics Evaluation and Research."
300   $a"Center for Devices and Radiological Health."
300   $a"Draft guidance."
300   $a"DDMAC."
300   $a"January 2004."
517   $aGuidance for industry 
606   $aAdvertising$xDrugs$zUnited States
606   $aAdvertising$zUnited States$xMedical instruments and apparatus
615  0$aAdvertising$xDrugs
615  0$aAdvertising$xMedical instruments and apparatus.
712 02$aCenter for Drug Evaluation and Research (U.S.)
712 02$aCenter for Biologics Evaluation and Research (U.S.)
712 02$aCenter for Devices and Radiological Health (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910696948203321
996   $aGuidance for industry$93434577
997   $aUNINA